Pallavi Rane

Costs of COPD exacerbations in the emergency department and inpatient setting

Anand A. Dalal, Manan Shah, Anna O. D’Souza et al. · Respiratory Medicine · 2010 · 108 citations

Medicine, Emergency Medicine, Pharmacoeconomics +14

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

Dionne M. Hines, Pallavi Rane, Jeetvan Patel et al. · Vascular Health and Risk Management · 2018 · 42 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations

Khalid M. Kamal, Shane P. Desselle, Pallavi Rane et al. · Drug Information Journal · 2009 · 20 citations

Pharmacy, Pharmaceutical Policy, Pharmaceutical Compliance +16

Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors

Pallavi Rane, Jeetvan Patel, David J. Harrison et al. · American Journal of Cardiovascular Drugs · 2017 · 20 citations

Medicine, Pharmacology, Pharmacotherapy +4

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

Seth J. Baum, Pallavi Rane, Sasikiran Nunna et al. · American Journal of Preventive Cardiology · 2021 · 16 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17